Yukinobu Nakagawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yukinobu Nakagawa has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Manabu Fujimoto
Department of Dermatology, Graduate School of Medicine The University of Osaka Osaka Japan
16 shared publicationsIchiro Katayama
Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan
14 shared publications- Eiji Kiyohara
Department of Dermatology The University of Osaka Graduate School of Medicine Suita Osaka Japan
9 shared publications - Manabu Fujimoto
Department of Dermatology The University of Osaka Graduate School of Medicine Suita Japan
9 shared publications - Yorihisa Kotobuki
Department of Dermatology Osaka University Graduate School of Medicine Osaka Japan
8 shared publications - Atsushi Tanemura
Department of Dermatology The University of Osaka Graduate School of Medicine Suita Osaka Japan
6 shared publications
Latest Publications
- 20 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11)
Refractory Epidermolysis Bullosa Acquisita Treated With Apremilast
- 20 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11)
Refractory Epidermolysis Bullosa Acquisita Treated With Apremilast
- 26 April 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (7)
A case of anti‐p200 pemphigoid associated with myasthenia gravis
- 26 April 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (7)
A case of anti‐p200 pemphigoid associated with myasthenia gravis
- 24 June 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (12) , e433-e434
Development of bullous pemphigoid with autoantibodies against full‐length BP180 following COVID‐19 infection
- 24 June 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (12) , e433-e434
Development of bullous pemphigoid with autoantibodies against full‐length BP180 following COVID‐19 infection
- Open Access
- 27 December 2023
- Published by Elsevier in Allergology International
- Vol. 73 (2) , 332-334
Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
- 27 December 2023
- Published by Elsevier in Allergology International
- Vol. 73 (2) , 332-334
Open AccessExploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
- 24 May 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (10) , E335-E336
A case of thiamazole‐induced erythema nodosum
- 24 May 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (10) , E335-E336
A case of thiamazole‐induced erythema nodosum
- 25 June 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (11) , E417-E418
A case of anti‐RNA polymerase III antibody‐positive systemic sclerosis with generalized morphea‐like lesions correlated with elevation of peripheral eosinophil counts
- 25 June 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (11) , E417-E418
A case of anti‐RNA polymerase III antibody‐positive systemic sclerosis with generalized morphea‐like lesions correlated with elevation of peripheral eosinophil counts
- Open Access
- 25 March 2022
- Published by Elsevier in Allergology International
- Vol. 71 (3) , 420-422
Development of alopecia areata-like reactions in a patient treated with dupilumab
- 25 March 2022
- Published by Elsevier in Allergology International
- Vol. 71 (3) , 420-422
Open AccessDevelopment of alopecia areata-like reactions in a patient treated with dupilumab
- Open Access
- 1 January 2022
- Published by Elsevier in Allergology International
- Vol. 71 (1) , 158-160
Refractory dermatomyositis which developed in a patient with silicone breast implants
- 1 January 2022
- Published by Elsevier in Allergology International
- Vol. 71 (1) , 158-160
Open AccessRefractory dermatomyositis which developed in a patient with silicone breast implants
- 12 July 2021
- Published by Springer Nature in Head and Neck Pathology
- Vol. 16 (2) , 560-566
Clear Cell Carcinoma in the Oral Cavity with Three Novel Types of EWSR1-ATF1 Translocation: A Case Report
Clear cell carcinoma (CCC) is a rare epithelial malignant tumor of the salivary glands. It is characterized by tumor cells with clear cytoplasm, hyalinized stroma, and most importantly the fusion genes EWSR1-ATF1, EWSR1-CREM, and EWSR1-PLAG1. Break-apart FISH has been performed for multiple CCC cases, but direct sequencing analysis has been performed in relatively few. Herein, we report an interesting case of CCC harboring three EWSR1-ATF1 translocations: EWSR1 exon 8-ATF1 exon 4, EWSR1 exon 7-ATF1 exon 4, and EWSR1 exon 7-ATF1 exon 5. This case indicates the possibility of independent EWSR1-ATF1 gene translocations, and could provide insight into CCC tumorgenesis.
- 12 July 2021
- Published by Springer Nature in Head and Neck Pathology
- Vol. 16 (2) , 560-566
Clear Cell Carcinoma in the Oral Cavity with Three Novel Types of EWSR1-ATF1 Translocation: A Case Report
Clear cell carcinoma (CCC) is a rare epithelial malignant tumor of the salivary glands. It is characterized by tumor cells with clear cytoplasm, hyalinized stroma, and most importantly the fusion genes EWSR1-ATF1, EWSR1-CREM, and EWSR1-PLAG1. Break-apart FISH has been performed for multiple CCC cases, but direct sequencing analysis has been performed in relatively few. Herein, we report an interesting case of CCC harboring three EWSR1-ATF1 translocations: EWSR1 exon 8-ATF1 exon 4, EWSR1 exon 7-ATF1 exon 4, and EWSR1 exon 7-ATF1 exon 5. This case indicates the possibility of independent EWSR1-ATF1 gene translocations, and could provide insight into CCC tumorgenesis.